Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Total Current Liabilities came in at $963.7 million in Q2 2026, up 2.27% on a YoY basis from $942.3 million in Q2 2025, and up 3.72% quarter-over-quarter from $929.1 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Total Current Liabilities for 5 consecutive years, with $963.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities rose 2.27% year-over-year to $963.7 million; the trailing twelve-month figure through Jun 2026 stood at $963.7 million (up 2.27% YoY), and the FY2025 full-year result was $913.3 million, down 3.81% from the prior year.
  • Total Current Liabilities grew to $963.7 million in Q2 2026 per FTRE's latest filing, from $929.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $999.1 million in Q1 2025 and bottomed at $699.0 million in Q4 2022.
  • Historically, Total Current Liabilities has averaged $855.6 million across 5 years, with a median of $865.8 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Total Current Liabilities grew 25.81% in 2025, then dropped 7.01% in 2026.
  • Over 5 years, Total Current Liabilities stood at $699.0 million in 2022, then gained by 11.36% to $778.4 million in 2023, then rose by 21.98% to $949.5 million in 2024, then slipped by 3.81% to $913.3 million in 2025, then gained by 5.52% to $963.7 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $963.7 million, $929.1 million, and $913.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 8.82 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 1.44 Bn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 1.13 Bn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 3.93 Bn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 963.70 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - 363.19 Mn
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 72.74 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 19.92 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 4.22 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn - 1.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 963.70 Mn
Mar 31, 2026 929.10 Mn
Dec 31, 2025 913.30 Mn
Sep 30, 2025 914.40 Mn
Jun 30, 2025 942.30 Mn
Mar 31, 2025 999.10 Mn
Dec 31, 2024 949.50 Mn
Sep 30, 2024 795.80 Mn
Jun 30, 2024 749.00 Mn
Mar 31, 2024 818.30 Mn
Dec 31, 2023 778.40 Mn
Sep 30, 2023 774.60 Mn
Jun 30, 2023 752.10 Mn
Dec 31, 2022 699.00 Mn